Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0OBPOE
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Trastuzumab-LD3
|
|||||
| Synonyms |
Trastuzumab-LD3
Click to Show/Hide
|
|||||
| Organization |
BYONDIS B.V.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1.9
|
|||||
| Structure |
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Seco-DUBA
|
Payload Info | ||||
| Therapeutic Target |
Human deoxyribonucleic acid (hDNA)
|
Target Info | ||||
| Linker Name |
Trastuzumab-LD3-LINKER
|
Linker Info | ||||
| Combination Type |
LD3
|
|||||